Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

President’s Perspective: ACR Calls on Members to Advance Rheumatology

Audrey B. Uknis, MD  |  Issue: April 2013  |  April 1, 2013

Audrey B. Uknis, MD
Audrey B. Uknis, MD


In his speech in Cape Town, South Africa, in 1966, Robert F. Kennedy referenced the saying, “may you live in interesting times.” Indeed, today we live in not only interesting times, but amazing times. Along with continual advances in technology, true breakthroughs in treatment for our patients, and the rapid transformation of the healthcare landscape, reforms are in development that could substantially alter the physician payment system for the first time since 1997. Also of great concern is the threat of ongoing decreases in National Institutes of Health (NIH) funding, undermining the future of discovery and the health of our research and training enterprises—threats that have the potential to intensify the crisis in our already stressed workforce.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Strength to Seize this Moment
ACR President Audrey B. Uknis, MD, Treasurer E. William St.Clair, MD, Past President James O’Dell, MD, and, President-Elect Joseph Flood, MD, (left to right) advocating on Capitol Hill.

President John F. Kennedy noted, “To those whom much is given, much is required.” With these amazing times in which we live, there comes a responsibility to seize this moment. I have confidence that the ACR, with the strength of conviction and sense of responsibility of our members, has the capability to seize this moment of unprecedented opportunity. Each of us must contribute to the collective effort that will shape the future of healthcare.

Shaping the Future of Physician Payments

Medicare’s physician payment formula—the Sustainable Growth Rate (SGR) formula—dates back to 1997. Over the past decade, rheumatologists and other physicians have faced increasingly large cuts, and Congress has had to step in 16 times with short-term patches to prevent drastic consequences. The ongoing threat of cuts continues to jeopardize patient access to rheumatologists. Just as problematic is this system’s focus on rewarding volume rather than quality of care. The undervaluation of nonprocedural, face-to-face care and coordination also jeopardizes patient access to care and the very future of cognitive specialties like rheumatology.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Our lawmakers agree that the SGR must be replaced with a more rational formula. Expertise and quality of care must be recognized as more critical than quantity of care. Moreover, the experts in the field must be responsible for setting the standards for excellence; advanced training and clinical expertise must be a critical part of any successful formula.

The good news is that we have the opportunity—and the responsibility—to work together to help shape how reform moves forward. The ACR has been working with the key committees in Congress over the past two years on components of a “repeal and replace” plan to deal with the SGR. Chairman Fred Upton, of the powerful Energy and Commerce Committee, has said that he wants a bill on the floor of Congress before August. In addition to other recommendations, we are asking that the bill include a provision to reverse the 2% sequester cuts to Medicare payments that went into effect in April.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:AC&RAdvocacyCongressrheumatology

Related Articles

    Speak Up: Ask Congress to Block Medicare Reimbursement Cuts

    October 22, 2021

    Rheumatologists may need to downsize and restrict patient care if Congress doesn’t act to block significant cuts to Medicare reimbursement rates totaling 9.75% in 2022.

    Update on Legislation, Advocacy Efforts to Advance Rheumatology

    September 1, 2014

    Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

    Much at Stake for Rheumatology in Lame Duck Session of Congress

    December 1, 2012

    Massive mandatory spending cuts—including a near 30% cut to Medicare physician reimbursement—are scheduled to go into effect in January

    Rehabilitation and Myositis

    January 1, 2008

    Physical therapy to manage inflammatory muscle disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences